ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Onesource Specialty Pharma Limited has allotted 900 equity shares under its Employee Stock Option Plan. This allotment updates the company's total paid-up share capital.
OneSource Specialty Pharma allotted 900 shares under its ESOP 2021 scheme at an exercise price of ₹278 per share, totaling ₹0.03 Crore.
Onesource Specialty Pharma Limited appointed B S R & Co LLP as its Statutory Auditor for a 60-month term, effective September 23, 2026.
OneSource Specialty Pharma Ltd appointed M/s B S R & Co LLP as its Statutory Auditors for a five-year term ending at the 24th AGM.
OneSource Specialty Pharma held its 19th Annual General Meeting on September 23, 2026. Shareholders transacted ordinary and special business items, including re-appointments and related party approvals.
OneSource Specialty Pharma issued an addendum to its 19th AGM notice regarding additional disclosures for agenda items about material related party transactions.
OneSource reported strong Q1 FY27 results with Revenue of INR 4,490M (up 37% YoY) and EBITDA of INR 1,233M (up 39% YoY), driven by semaglutide commercialization and biologics expansion.
OneSource Specialty Pharma Limited has submitted its Business Responsibility & Sustainability Report for the financial year ended March 31, 2026, as required by regulation.
OneSource Specialty Pharma Limited has released its Integrated Annual Report for FY 2025-26 and scheduled its 19th AGM for September 23, 2026.
Onesource Specialty Pharma has issued a notice for its 19th Annual General Meeting scheduled for September 23, 2026. The meeting will address financial statements and director appointments.
India Ratings has upgraded OneSource Specialty Pharma Limited's long-term credit rating to 'IND A' with a Positive outlook. Short-term ratings were affirmed at 'IND A1'.